These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11792007)

  • 41. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.
    Brault AC; Powers AM; Ortiz D; Estrada-Franco JG; Navarro-Lopez R; Weaver SC
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11344-9. PubMed ID: 15277679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pathomorphogenesis of experimental infection produced in Syrian hamsters by an attenuated strain of Venezuelan equine encephalitis virus. 2. Histopathologic residual modifications in the brain].
    Dremov DP
    Arch Roum Pathol Exp Microbiol; 1977; 36(1):87-95. PubMed ID: 603387
    [No Abstract]   [Full Text] [Related]  

  • 45. Alteration of virulence of Venezuelan equine encephalomyelitis virus after passage in L cell cultures and in mice.
    HEARN HJ; BROWN A; HARDY FM
    J Infect Dis; 1961; 108():237-42. PubMed ID: 13712595
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pathomorphogenesis of experimental infection produced in Syrian hamsters by an attenuated strain of Venezuelan equine encephalitis virus. 1. Acute and subacute phases of the infection].
    Dremov DP
    Arch Roum Pathol Exp Microbiol; 1977; 36(1):79-86. PubMed ID: 603386
    [No Abstract]   [Full Text] [Related]  

  • 47. The formation of plaques by two strains of Venezuelan equine encephalomyelitis virus.
    HARDY FM; HEARN HJ
    Am J Hyg; 1961 May; 73():258-62. PubMed ID: 13711514
    [No Abstract]   [Full Text] [Related]  

  • 48. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus.
    Walton TE; Alvarez O; Buckwalter RM; Johnson KM
    J Infect Dis; 1973 Sep; 128(3):271-82. PubMed ID: 4728689
    [No Abstract]   [Full Text] [Related]  

  • 50. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Venezuelan equine encephalitis: state-of-the-art].
    Anishchenko M; Alekseev VV; Lipnitskiĭ AV
    Vopr Virusol; 2006; 51(6):10-3. PubMed ID: 17214075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postepizootic persistence of Venezuelan equine encephalitis virus, Venezuela.
    Navarro JC; Medina G; Vasquez C; Coffey LL; Wang E; Suárez A; Biord H; Salas M; Weaver SC
    Emerg Infect Dis; 2005 Dec; 11(12):1907-15. PubMed ID: 16485478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A slit sampler for collecting T-3 bacteriophage and Venezuelan equine encephalomyelitis virus. II. Studies with Venezuelan equine encephalomyelitis virus.
    KUEHNE RW; GOCHENOUR WS
    Appl Microbiol; 1961 Mar; 9(2):106-7. PubMed ID: 13754875
    [No Abstract]   [Full Text] [Related]  

  • 54. Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus.
    Bhalla N; Sun C; Metthew Lam LK; Gardner CL; Ryman KD; Klimstra WB
    Virology; 2016 Sep; 496():147-165. PubMed ID: 27318152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-factorial specification of virus-host interactions: studies with strains of Venezuelan equine encephalomyelitis virus in mice.
    Walder R; Bradish CJ
    J Gen Virol; 1979 Aug; 44(2):373-82. PubMed ID: 521796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [INHIBITION OF THE GROWTH OF THE VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS WITH THE USE OF PUROMYCIN].
    ZHDANOV VM; ERSHOV FI
    Antibiotiki; 1965 Mar; 10():255-9. PubMed ID: 14294745
    [No Abstract]   [Full Text] [Related]  

  • 57. [MULTIPLICATION OF THE VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS IN CELLS TREATED WITH ACTINOMYCIN D].
    ERSHOV FI; ZHDANOV VM; TSAREVA AA
    Antibiotiki; 1965 Mar; 10():250-5. PubMed ID: 14294744
    [No Abstract]   [Full Text] [Related]  

  • 58. The growth of Venezuelan equine encephalomyelitis virus in various tissue cultures.
    HARDY FM
    Am J Hyg; 1959 Jul; 70(1):21-7. PubMed ID: 13670164
    [No Abstract]   [Full Text] [Related]  

  • 59. Venezuelan equine encephalitis virus: comparison of infectivity and virulence of strains V-38 and P676 in donkeys.
    Mackenzie RM; de Siger J; Parra D
    Am J Trop Med Hyg; 1976 May; 25(3):494-9. PubMed ID: 937636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Venezuelan equine encephalitis.
    Weaver SC; Ferro C; Barrera R; Boshell J; Navarro JC
    Annu Rev Entomol; 2004; 49():141-74. PubMed ID: 14651460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.